Status:
COMPLETED
Predictive Study of Radiation Induced Sarcoma
Lead Sponsor:
Centre Georges Francois Leclerc
Conditions:
Radiation Induced Sarcoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Development of sarcoma within or adjacent to radiation field is a well known event of poor prognosis and unknown risk factors. Advanced techniques of radiation therapy including intensity modulated ra...
Detailed Description
The biological study will include the two following steps:1. On frozen specimen: genic profile of the tumor will be studied with two different techniques: CGH-array from extracted DNA in order to eval...
Eligibility Criteria
Inclusion
- radiation-induced sarcoma group
- Age \> 18 ans when radiation was performed
- suffering from a radiation induced sarcoma
Exclusion
- private individuals of freedom or under tutelage (including legal guardianship)
- initial tumor treated by radiotherapy was a sarcoma
- patient bearer of an osteosarcoma
- Free from irradiation induced sarcoma group
- Inclusion Criteria:
- Age \> 18 ans when radiation was performed
- surviving irradiated patients for cancer for more than 5 years and free of from radiation-induced sarcoma.
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT01504360
Start Date
December 1 2011
End Date
June 1 2017
Last Update
June 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CGFL
Dijon, France, 21079